Table 3.
Potential benefit of POCT | Complicating factors |
---|---|
Reduced unnecessary antibiotic use | Co-infection with bacteria is common |
Improved antiviral usea | Ongoing controversy over efficacy of neuraminidase inhibitors |
Improved isolation facility use | Increased detection of viruses may stretch limited resources |
Reduced economic cost | Health economic modelling assumption are largely speculative |
Currently only neuraminidase inhibitors for influenza.